Bleakley Financial Group LLC Cuts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Bleakley Financial Group LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.1% in the 4th quarter, Holdings Channel reports. The institutional investor owned 24,094 shares of the healthcare conglomerate’s stock after selling 1,576 shares during the quarter. Bleakley Financial Group LLC’s holdings in UnitedHealth Group were worth $12,188,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Vision Capital Management Inc. acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $272,000. Meadow Creek Wealth Advisors LLC grew its stake in shares of UnitedHealth Group by 1.9% in the fourth quarter. Meadow Creek Wealth Advisors LLC now owns 2,766 shares of the healthcare conglomerate’s stock valued at $1,399,000 after buying an additional 52 shares in the last quarter. Tyche Wealth Partners LLC lifted its position in shares of UnitedHealth Group by 7.3% during the fourth quarter. Tyche Wealth Partners LLC now owns 4,683 shares of the healthcare conglomerate’s stock worth $2,369,000 after purchasing an additional 318 shares in the last quarter. Summit Wealth Partners LLC grew its stake in shares of UnitedHealth Group by 14.2% during the fourth quarter. Summit Wealth Partners LLC now owns 1,684 shares of the healthcare conglomerate’s stock valued at $852,000 after acquiring an additional 209 shares in the last quarter. Finally, Vanderbilt University boosted its stake in shares of UnitedHealth Group by 1.7% during the 4th quarter. Vanderbilt University now owns 7,867 shares of the healthcare conglomerate’s stock valued at $3,980,000 after buying an additional 131 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on UNH. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a report on Friday, January 10th. Oppenheimer upped their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. KeyCorp reiterated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Bank of America cut their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Trading Down 1.1 %

UnitedHealth Group stock opened at $539.50 on Thursday. The firm has a market capitalization of $496.49 billion, a PE ratio of 34.81, a PEG ratio of 1.48 and a beta of 0.61. The business’s 50-day simple moving average is $533.81 and its 200-day simple moving average is $564.94. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the company posted $5.83 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current year.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.